Monitoring donor specific HLA-antibodies developed after kidney transplantation (de novo DSA)
Hauzenberger D, Lindström K, Wennberg L, Lennmarken C, Blom M, Berg N, Hermansson J
Record ID 32014000534
Swedish
Authors' objectives:
Does monitoring of de novo DSA after kidney transplantation provide earlier identification of transplant dysfunction or rejection, fewer loss of transplant grafts or patients back in dialysis or improved patient survival?
Authors' recommendations:
The question whether dysfunction or rejection of a transplanted kidney can be detected earlier by adding monitoring of de novo DSA after transplantation cannot be answered. The level of evidence according to GRADE is insufficient (⊕). Due to the study designs the questions whether monitoring of de novo DSA after kidney transplantation reduces loss of transplants alternatively patients back in dialysis or improved patient survival cannot be answered.
Details
Project Status:
Completed
Year Published:
2013
URL for published report:
http://www.vardgivarguiden.se/utbildningutveckling/Vardutveckling/HT
A/HTA1/Donor-specific-antibodies-HTA-report-20137/
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Sweden
MeSH Terms
- HLA Antigens
- Kidney Transplantation
Contact
Organisation Name:
The HTA Center of the Stockholm County Council/Gotland
Contact Address:
HTA Region Stockholm, Centre for Health Economics, Informatics and Health Care Research (CHIS), Stockholm Health Care Services, Tomtebodavägen 18A, pl 4, 171 65 Solna, Sweden
Contact Name:
eva.fjellgren@regionstockholm.se
Contact Email:
hta.slso@regionstockholm.se
Copyright:
The Stockholm County Council
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.